ISOFLURANE PRODUCES ENDOTHELIUM-INDEPENDENT RELAXATION IN CANINE MIDDLE CEREBRAL-ARTERIES
ISOFLURANE PRODUCES ENDOTHELIUM-INDEPENDENT RELAXATION IN CANINE MIDDLE CEREBRAL-ARTERIES
复制标题
DOI:
10.1097/00000542-199203000-00021
复制
发表时间:
1992-03-01
期刊:
影响因子:
8.8
通讯作者:
KAMPINE, JP
中科院分区:
文献类型:
--
作者:
FLYNN, NM;BULJUBASIC, N;KAMPINE, JP
Although it is generally accepted that isoflurane can cause cerebral vasodilation, the sensitivity of the cerebral vessels to this anesthetic agent remains controversial. Furthermore, the mechanism by which isoflurane produces its direct effects on the cerebral vasculature remains unknown. The purpose of this study was to determine if isoflurane-induced relaxation of canine middle cerebral arteries is dose-dependent and/or endothelium-dependent. In an additional series of experiments, isoflurane-induced relaxation was studied in the presence of indomethacin to inhibit prostacyclin release, and endothelium-independent relaxation was examined with sodium nitroprusside. The response to isoflurane was examined in middle cerebral arteries prior to and following pretreatment with 300-mu-M N(G)-monomethyl-L-arginine (LnMMA), an inhibitor of endothelium-dependent vasodilation. Vascular rings (2.5 mm in length and 600-800-mu-m in diameter) were suspended in tissue baths and isometric tension recorded. The rings were constricted with either 0.2-mu-m 5-hydroxytryptamine or 5-mu-m prostaglandin F2-alpha and subsequently exposed to increasing concentrations of isoflurane (0.65-4.9%). In separate experiments the procedure was repeated in vessels with and without endothelium. Isoflurane produced a dose-dependent relaxation in all vessels. This relaxation was not inhibited by LnMMA and was unaffected by the absence of endothelium. The isoflurane response was independent of cyclooxygenase inhibition. These results demonstrate that isoflurane-induced relaxation of canine middle cerebral arteries: 1) is dose-dependent; 2) is not mediated by modulation of endothelium-derived relaxing factor or a release of prostacyclin; and 3) is endothelium-independent.